Article Sidebar

PDF (Tiếng Việt)
Published: 2021-05-31
Abstract Views: 695
Views PDF (Tiếng Việt): 758
DOI: https://doi.org/10.52852/tcncyh.v138i2.73
Issue
Vol. 138 No. 2 (2021)
Section
Các bài báo
How to Cite
Anh, P. T. V., Hoa, H. Q., Giang, P. T. L., Kim, L. T., Quang, L. A., & Thanh, M. P. (2021). Hypouricemic action of vitagout capsules on potassium oxonate-induced elevation of blood uric acid concentration. Journal of Medical Research, 138(2), 63-68. https://doi.org/10.52852/tcncyh.v138i2.73

Hypouricemic action of vitagout capsules on potassium oxonate-induced elevation of blood uric acid concentration

Phạm Thị Vân Anh, Hoàng Quỳnh Hoa, Phạm Thị Linh Giang, Lê Thiên Kim, Lê Anh Quang, Mai Phương Thanh

Main Article Content

Abstract

This study assessed the effects of VitaGout at the doses of 1.2 g herbal raw materials/day and 3.6 g herbal raw materials/day on the serum uric acid level  in animal model of hyperuricemia using mice pretreated with the uricase inhibitor potassium oxonate. The mice were intragastrically administered with drugs once a day for 5 consecutive daysin order to determine their concentration of uric acid in serum and urine, and fractional excretion of uric acid. Subsequently, induced elevation of blood uric acid level was done by administering oxonate at 500mg/kg. VitaGout dose of 3.6 herbal raw materials/day significantly lowered blood uric acid level. In addition, both test doses of VitaGout significantly lowered the urine uric acid levels and fractional excretion of uric acid. These results demonstrated the hypouricemic action of VitaGout at the dose of 3.6 g herbal raw materials/day, which might not be associated with uricosuric activity.

Article Details

Keywords

VitaGout, uric acid, mice.

References

1. Jameson JL. Gout and other crystal-associated arthropathies. Harrison’s Principles of Internal Medicine, 20th edition, McGraw-Hill Education 2018, 2631-2636.
2. Roddy E, Choi HK. Epidemiology of gout. Rheum Dis Clin North Am. 2014;40(2):155-175. doi:10.1016/j.rdc.2014.01.001.
3. Chandratre P, Roddy E, Clarson L, et al. Health-related quality of life in gout: a systematic review. Rheumatology (Oxford). 2013;52(11):2031-2040.
4. Richette P. Chapter 44: Principles of gout management. Oxford Textbook of Osteoarthritis and Crystal Arthropathy, 3rd edition, Oxford University Press 2016, 431-434.
5. Brunton LL. Chapter 38: Pharmacotherapy of Inflammation, Fever, Pain, and Gout. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics, 13th edition, McGraw-Hill Education 2018, 687-709.
6. Etani R, Kataoka T, Kanzaki N, et al. Difference in the action mechanism of radon inhalation and radon hot spring water drinking in suppression of hyperuricemia in mice. J Radiat Res. 2016;57(3):250-257.
7. Shah PA, Shah GB. Uricosuric activity of Tinospora cordifolia. Bangladesh J Pharmacol. 2019;10:884-890.
8. Rafey MA, Lipkowitz MS, Leal-Pinto E, and Abramson RG. Uric acid transport. Curr Opin Nephrol Hypertens. 2003;12:511-516.
9. Nguyen MT, Awale S, Tezuka Y, et al. Xanthine oxidase inhibitory activity of Vietnamese medicinal plants. Biol Pharm Bull. 2004;27(9):1414-1421.
10. HemRaj V, Gupta A, Upmanyu N. Anti-Arthritics Activity of I Leaves and Stephania glabra Rhizome Ethanolic Extract on Adjuvant and Potassium Oxonate Treated Rat. The Open Rheumatology Journal. 2019;13:45-52.
11. Konno H, Kanai Y, Katagiri M, et al. Melinjo (Gnetum gnemon L.) Seed Extract Decreases Serum Uric Acid Levels in Nonobese Japanese Males: A Randomized Controlled Study. Evid Based Complement Alternat Med. 2013;2013:589169. doi:10.1155/2013/589169.